TP53 and cancer: We hypothesized that triggering the death receptor signaling in the cancer cells could omit the need for p53 or other defective intrinsic apoptotic pathways, thereby crooking an important path that normal cells overcome (TRAIL-induced apoptosis is relatively selective for transformed cells) [30].